Illinois Biotechnology Innovation Organization Announces Astellas’ Walt Johnston as New Chairman
Thursday, 07 December 2017 05:06
Dec. 7, 2017 16:00 UTC

Illinois Biotechnology Innovation Organization Announces Astellas’ Walt Johnston as New Chairman

CHICAGO--(BUSINESS WIRE)-- Astellas’ Walt Johnston has been elected as chairman of the iBIO and iBIO Institute Boards of Directors. He succeeds Timothy P Walbert, Horizon Pharma, who served as chairman for the past two years and who will continue to serve on the Board and Executive Committee as Immediate Past Chairman.

iBIO, founded in 2002, is the industry organization representing life sciences companies in the biomedical pharmaceutical, medical device and food and bio agricultural sectors in Illinois. iBIO has over 100 members ranging from early-stage startup to Fortune 500 companies.

The iBIO Institute was established in 2003 by iBIO to orchestrate business leadership in delivery of world-class educational programs and job-creating new technology ventures.

Walt Johnston is senior vice president, sales and

marketing, urology and

Error. Page cannot be displayed. Please contact your service provider for more details. (19)

hospital business unit at Astellas. In this role, he is responsible for leading Astellas’ US commercial activities. Johnston is a member of the Astellas US Management Committee and
Portfolio Steering Committee Executive Committee.

Johnston joined Astellas in 2008 as vice president, marketing and new product planning, where he led all strategic marketing activities for on-market and development products for the United States business.

“Walt’s commitment to establishing Chicago and Illinois as a thriving biopharmaceutical and life sciences hub, along with his business acumen makes him an ideal person for this role,” said iBIO Interim President and CEO, John Conrad. “Astellas is a leading organization in our community and having Walt’s caliber of leadership as our chairman will be an invaluable asset to our organization and members.”

Prior to joining Astellas, Johnston worked at Pfizer for 18 years in positions of increasing responsibility for marketing and sales, where he drove key strategic initiative for the cardiovascular portfolio, including Lipitor and Caduet.

“I am honored to be elected chairman and look forward to working with iBIO’s leadership to continue to make Illinois a globally recognized life sciences center,” said Johnston. “Our community has all of the elements needed to cultivate a sustainable biotech and science ecosystem, and it’s exciting to be a part of the continued growth and innovation.”

About the Illinois Biotechnology Innovation Organization

iBIO’s mission is to make Illinois and the surrounding Midwest one of the world’s top life sciences centers: a great place to do business and a great place to grow technology ventures.

iBIO’s Leadership Sponsors are AbbVie, Astellas US, Horizon Pharma, Shire and Takeda Pharmaceuticals North America.

About the iBIO Institute

The iBIO Institute is a 501(c)(3) non-profit that focuses on orchestrating business leadership in delivery of world-class, educational programs and job-creating new technology ventures.

Contacts

iBIO
John Conrad, 312-422-1111
jconrad@ibio.org
www.ibio.org


Source: iBIO




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 
BMR:1